Inventiva SA
PAR:IVA
Inventiva SA
Cash from Operating Activities
Inventiva SA
Cash from Operating Activities Peer Comparison
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Inventiva SA
PAR:IVA
|
Cash from Operating Activities
-€81.6m
|
CAGR 3-Years
-39%
|
CAGR 5-Years
-19%
|
CAGR 10-Years
N/A
|
|
Valneva SE
PAR:VLA
|
Cash from Operating Activities
-€202.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-26%
|
|
Innate Pharma SA
PAR:IPH
|
Cash from Operating Activities
-€32.6m
|
CAGR 3-Years
14%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-11%
|
|
G
|
Genfit SA
PAR:GNFT
|
Cash from Operating Activities
-€55.4m
|
CAGR 3-Years
17%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-20%
|
Cellectis SA
PAR:ALCLS
|
Cash from Operating Activities
-$74.6m
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
Abivax SA
PAR:ABVX
|
Cash from Operating Activities
-€97.1m
|
CAGR 3-Years
-48%
|
CAGR 5-Years
-46%
|
CAGR 10-Years
N/A
|
See Also
What is Inventiva SA's Cash from Operating Activities?
Cash from Operating Activities
-81.6m
EUR
Based on the financial report for Dec 31, 2023, Inventiva SA's Cash from Operating Activities amounts to -81.6m EUR.
What is Inventiva SA's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
-19%
Over the last year, the Cash from Operating Activities growth was -82%. The average annual Cash from Operating Activities growth rates for Inventiva SA have been -39% over the past three years , -19% over the past five years .